313 related articles for article (PubMed ID: 17595666)
1. Expression of VEGF(xxx)b, the inhibitory isoforms of VEGF, in malignant melanoma.
Pritchard-Jones RO; Dunn DB; Qiu Y; Varey AH; Orlando A; Rigby H; Harper SJ; Bates DO
Br J Cancer; 2007 Jul; 97(2):223-30. PubMed ID: 17595666
[TBL] [Abstract][Full Text] [Related]
2. The transcription factor E2F1 and the SR protein SC35 control the ratio of pro-angiogenic versus antiangiogenic isoforms of vascular endothelial growth factor-A to inhibit neovascularization in vivo.
Merdzhanova G; Gout S; Keramidas M; Edmond V; Coll JL; Brambilla C; Brambilla E; Gazzeri S; Eymin B
Oncogene; 2010 Sep; 29(39):5392-403. PubMed ID: 20639906
[TBL] [Abstract][Full Text] [Related]
3. The anti-angiogenic isoforms of VEGF in health and disease.
Qiu Y; Hoareau-Aveilla C; Oltean S; Harper SJ; Bates DO
Biochem Soc Trans; 2009 Dec; 37(Pt 6):1207-13. PubMed ID: 19909248
[TBL] [Abstract][Full Text] [Related]
4. Diabetic retinopathy is associated with a switch in splicing from anti- to pro-angiogenic isoforms of vascular endothelial growth factor.
Perrin RM; Konopatskaya O; Qiu Y; Harper S; Bates DO; Churchill AJ
Diabetologia; 2005 Nov; 48(11):2422-7. PubMed ID: 16193288
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of vascular endothelial growth factor-A isoforms at different stages of melanoma progression.
Gorski DH; Leal AD; Goydos JS
J Am Coll Surg; 2003 Sep; 197(3):408-18. PubMed ID: 12946796
[TBL] [Abstract][Full Text] [Related]
6. Targeting SRPK1 to control VEGF-mediated tumour angiogenesis in metastatic melanoma.
Gammons MV; Lucas R; Dean R; Coupland SE; Oltean S; Bates DO
Br J Cancer; 2014 Jul; 111(3):477-85. PubMed ID: 25010863
[TBL] [Abstract][Full Text] [Related]
7. Epidermal hyperplasia overlying human melanoma correlates with tumour depth and angiogenesis.
McCarty MF; Bielenberg DR; Nilsson MB; Gershenwald JE; Barnhill RL; Ahearne P; Bucana CD; Fidler IJ
Melanoma Res; 2003 Aug; 13(4):379-87. PubMed ID: 12883364
[TBL] [Abstract][Full Text] [Related]
8. Expresson of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas.
Straume O; Akslen LA
Am J Pathol; 2001 Jul; 159(1):223-35. PubMed ID: 11438469
[TBL] [Abstract][Full Text] [Related]
9. Prognosis in human melanoma: PAR-1 expression is superior to other coagulation components and VEGF.
Depasquale I; Thompson WD
Histopathology; 2008 Mar; 52(4):500-9. PubMed ID: 18315603
[TBL] [Abstract][Full Text] [Related]
10. VEGF₁₂₁b and VEGF₁₆₅b are weakly angiogenic isoforms of VEGF-A.
Catena R; Larzabal L; Larrayoz M; Molina E; Hermida J; Agorreta J; Montes R; Pio R; Montuenga LM; Calvo A
Mol Cancer; 2010 Dec; 9():320. PubMed ID: 21194429
[TBL] [Abstract][Full Text] [Related]
11. S100A13 is a new angiogenic marker in human melanoma.
Massi D; Landriscina M; Piscazzi A; Cosci E; Kirov A; Paglierani M; Di Serio C; Mourmouras V; Fumagalli S; Biagioli M; Prudovsky I; Miracco C; Santucci M; Marchionni N; Tarantini F
Mod Pathol; 2010 Jun; 23(6):804-13. PubMed ID: 20208480
[TBL] [Abstract][Full Text] [Related]
12. [Alternative splicing of vascular endothelial growth factor A and ocular neovascularization].
Fan SJ; He SZ
Zhonghua Yan Ke Za Zhi; 2011 Apr; 47(4):373-7. PubMed ID: 21612688
[TBL] [Abstract][Full Text] [Related]
13. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
14. Balance of pro- versus anti-angiogenic splice isoforms of vascular endothelial growth factor as a regulator of neuroblastoma growth.
Peiris-Pagès M; Harper SJ; Bates DO; Ramani P
J Pathol; 2010 Oct; 222(2):138-47. PubMed ID: 20662003
[TBL] [Abstract][Full Text] [Related]
15. Enhanced expression of vascular endothelial growth factor in metastatic melanoma.
Salven P; Heikkilä P; Joensuu H
Br J Cancer; 1997; 76(7):930-4. PubMed ID: 9328154
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor C mRNA expression correlates with stage of progression in patients with melanoma.
Goydos JS; Gorski DH
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5962-7. PubMed ID: 14676121
[TBL] [Abstract][Full Text] [Related]
17. Transition of horizontal to vertical growth phase melanoma is accompanied by induction of vascular endothelial growth factor expression and angiogenesis.
Erhard H; Rietveld FJ; van Altena MC; Bröcker EB; Ruiter DJ; de Waal RM
Melanoma Res; 1997 Aug; 7 Suppl 2():S19-26. PubMed ID: 9578413
[TBL] [Abstract][Full Text] [Related]
18. The correlation of angiogenesis with metastasis in primary cutaneous melanoma: a comparative analysis of microvessel density, expression of vascular endothelial growth factor and basic fibroblastic growth factor.
Demirkesen C; Büyükpinarbaşili N; Ramazanoğlu R; Oğuz O; Mandel NM; Kaner G
Pathology; 2006 Apr; 38(2):132-7. PubMed ID: 16581653
[TBL] [Abstract][Full Text] [Related]
19. WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells.
Ekström EJ; Bergenfelz C; von Bülow V; Serifler F; Carlemalm E; Jönsson G; Andersson T; Leandersson K
Mol Cancer; 2014 Apr; 13():88. PubMed ID: 24766647
[TBL] [Abstract][Full Text] [Related]
20. Association of vascular endothelial growth factor expression with patohistological parameters of cutaneous melanoma.
Gacević M; Jović M; Zolotarevski L; Stanojević I; Novaković M; Miller K; Šuljagić V; Mijušković Ž; Vojvodić D
Vojnosanit Pregl; 2016 May; 73(5):449-57. PubMed ID: 27430109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
